Wellington Management Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,472,043
| Closed | -$150M | – | 1910 |
|
|
2023
Q2 | $150M | Buy |
1,472,043
+50,881
| +4% | +$5.19M | 0.03% | 451 |
|
|
2023
Q1 | $129M | Sell |
1,421,162
-86,720
| -6% | -$7.88M | 0.03% | 482 |
|
|
2022
Q4 | $57.3M | Sell |
1,507,882
-64,384
| -4% | -$2.45M | 0.01% | 652 |
|
|
2022
Q3 | $39.5M | Sell |
1,572,266
-2,437,394
| -61% | -$61.3M | 0.01% | 727 |
|
|
2022
Q2 | $122M | Sell |
4,009,660
-386,879
| -9% | -$11.8M | 0.02% | 489 |
|
|
2022
Q1 | $144M | Buy |
4,396,539
+143,562
| +3% | +$4.7M | 0.02% | 497 |
|
|
2021
Q4 | $112M | Buy |
4,252,977
+9,705
| +0.2% | +$256K | 0.02% | 600 |
|
|
2021
Q3 | $427M | Sell |
4,243,272
-83,196
| -2% | -$8.37M | 0.07% | 255 |
|
|
2021
Q2 | $612M | Sell |
4,326,468
-29,299
| -0.7% | -$4.15M | 0.1% | 208 |
|
|
2021
Q1 | $434M | Buy |
4,355,767
+10,043
| +0.2% | +$1M | 0.08% | 253 |
|
|
2020
Q4 | $537M | Buy |
4,345,724
+355,972
| +9% | +$44M | 0.1% | 204 |
|
|
2020
Q3 | $389M | Buy |
3,989,752
+248,053
| +7% | +$24.2M | 0.08% | 225 |
|
|
2020
Q2 | $584M | Buy |
3,741,699
+720,775
| +24% | +$112M | 0.13% | 154 |
|
|
2020
Q1 | $436M | Buy |
3,020,924
+628,250
| +26% | +$90.7M | 0.12% | 168 |
|
|
2019
Q4 | $489M | Buy |
2,392,674
+1,877,864
| +365% | +$384M | 0.1% | 194 |
|
|
2019
Q3 | $41.3M | Buy |
514,810
+10,231
| +2% | +$821K | 0.01% | 768 |
|
|
2019
Q2 | $47.6M | Buy |
+504,579
| New | +$47.6M | 0.01% | 772 |
|